Impact of acupressure combined with flexible pressure sensor manometry on anesthesia recovery in patients undergoing Bronchoalveolar lavage: a randomized controlled trial

穴位按摩联合柔性压力传感器测压法对支气管肺泡灌洗患者麻醉恢复的影响:一项随机对照试验

阅读:2

Abstract

BACKGROUND: Postoperative cough after bronchoalveolar lavage (BAL) is common and can delay recovery. We evaluated whether acupressure at Tiantu (CV22), Chize (LU5), and Taiyuan (LU9), quantified by a flexible pressure sensor, improves anesthesia recovery. METHODS: This single-center randomized controlled trial enrolled adults undergoing BAL under general anesthesia with a laryngeal mask airway. Patients were randomized 1:1 to receive acupressure (Group A) or routine PACU care without acupressure (Group C). In Group A, each acupoint was pressed sequentially for 3 min (CV22 → LU5 → LU9) with pressure recorded by a flexible sensor. Primary outcomes were cough severity and frequency; secondary outcomes included PACU time, heart rate, and complications such as tachycardia, hypertension, and stress urinary incontinence. RESULTS: A total of 120 patients were analyzed (60 in each group). Peak acupressure pressures were 30.2 N for CV22, 35.1 N for LU5, and 25.3 N for LU9, each peaking at 2.0 s. Compared with controls, patients receiving acupressure had a significantly shorter PACU stay (mean difference - 16.0 min, 95% CI - 18.9 to - 13.2), lower cough frequency (- 1.06 times/min, 95% CI - 1.83 to - 0.30), and reduced heart rate (- 9.5 beats/min, 95% CI - 13.7 to - 5.4). The incidence of moderate cough (10.0% vs. 48.3%, RR 0.21, 95% CI 0.09-0.46), severe cough (35.0% vs. 60.0%, RR 0.58, 95% CI 0.39-0.87), tachycardia (8.3% vs. 26.7%, RR 0.31, 95% CI 0.12-0.80), and stress urinary incontinence (6.7% vs. 23.3%, RR 0.29, 95% CI 0.10-0.82) was also significantly lower in the acupressure group. The frequency of sore throat and hemoptysis at six hours did not differ between groups. No adverse events related to acupressure were observed. CONCLUSIONS: Acupressure at CV22, LU5, and LU9, applied with quantified pressure, significantly reduced postoperative cough and related complications and shortened PACU recovery time after BAL. TRIAL REGISTRATION: ISRCTN18030444. Registered on October 25, 2024; retrospectively registered.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。